Company Monitoring Page for Boehringer-Ingelheim

latest headlines for company on cafepharma

Spotlight – Cystic fibrosis developers take a deep breath
EP Vantage
Mon, 02/27/23 - 10:02 am
Tags:
cystic fibrosis, MRNA, Vertex Pharmaceuticals, 4D Molecular Therapeutics, Arcturus Therapeutics, Arrowhead Pharmaceuticals, Boehringer Ingelheim, Eloxx Pharmaceuticals, Krystal Biotech, Moderna Therapeutics, Oxford BioMedica, ReCode Therapeutics, SpliSense, Sumitomo Pharmaceuticals, Tessera Therapeutics
New Report Reveals Pharmaceutical Industry Social Media Pioneers
LBB Online
Fri, 02/24/23 - 08:52 am
Tags:
Ogilvy Health, social media, Bristol Myers Squibb, Boehringer Ingelheim, Roche
Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate
Xtalks
Sun, 01/29/23 - 01:31 pm
Tags:
television ads, pharma marketing, DTC ads, AbbVie, Rinvoq, Dupixent, Sanofi, Regeneron, Skyrizi, Novo Nordisk, Ozempic, Jardiance, Eli Lilly, Boehringer Ingelheim, Rybelsus, Trulicity, Rexulti, Otsuka, Lundbeck, Tremfya, JNJ, Verzenio
Roche, Boehringer tap biosensor firms for patient studies
Pharmaphorum
Thu, 01/26/23 - 10:58 am
Tags:
Roche, Boehringer Ingelheim, patient monitoring, biosensors, clinical trials, Sysnav Healthcare, Strados Labs
Boehringer, Takeda make it into global top 15 employer list
Pharmaphorum
Tue, 01/17/23 - 10:25 am
Tags:
Boehringer Ingelheim, Takeda, Top Employers
Sanofi expects Zantac arbitration case with Boehringer Ingelheim to be resolved early this year
Endpoints
Wed, 01/4/23 - 05:16 pm
Tags:
Sanofi, Boehringer Ingelheim, Zantac, legal
Boehringer Ingelheim deepens its collaboration with Click Therapeutics in a deal worth $460M
Endpoints
Mon, 12/19/22 - 10:07 pm
Tags:
Boehringer Ingelheim, Click Therapeutics, digital therapeutics, schizophrenia
Lilly and Boehringer's Jardiance Racks Up Another Type 2 Diabetes Win
BioSpace
Wed, 12/7/22 - 11:40 pm
Tags:
Eli Lilly, Boehringer Ingelheim, type 2 diabetes, Jardiance, pediatri
Eli Lilly, Boehringer Ingelheim bolster case for Jardiance to treat chronic kidney disease
Fierce Pharma
Sun, 11/6/22 - 01:44 pm
Tags:
Eli Lilly, Boehringer Ingelheim, chronic kideny disease, Jardiance, Farxiga, AstraZeneca
Seeking Ofev successor, Boehringer takes PDE4B drug into phase 3
Pharmaphorum
Thu, 10/27/22 - 10:41 am
Tags:
Boehringer Ingelheim, BI 1015550, IPH
Boehringer and Surrozen Seek Retinal Therapies Along the Wnt Pathway
BioSpace
Fri, 10/7/22 - 10:39 am
Tags:
Boehringer Ingelheim, Surrozen, Wnt pathway, retinal diseases, R&D
Boehringer Ingelheim preps FDA submission with new data in rare pediatric lung disease
Endpoints
Tue, 09/6/22 - 05:00 pm
Tags:
Boehringer Ingelheim, nintedanib, Ofev
Boehringer reports Phase III data for nintedanib in interstitial lung disease
Clinical Trials Arena
Tue, 09/6/22 - 10:45 am
Tags:
Boehringer Ingelheim, clinical trials, nintedanib, interstitial lung disease
Boehringer Ingelheim finally has skin in the game, scoring its first dermatology FDA nod
Fierce Pharma
Fri, 09/2/22 - 12:19 pm
Tags:
Boehringer Ingelheim, FDA, dermatology, GPP, Spevigo
In damage control mode, Perrigo clarifies that it's off the hook in key Zantac case
Fierce Pharma
Thu, 08/18/22 - 11:18 pm
Tags:
Perrigo, Boehringer Ingelheim, GSK, legal, Zantac
Boehringer takes on antimicrobial resistance with Evotec, bioMérieux JV
Pharmaforum
Wed, 07/6/22 - 11:00 am
Tags:
Boehringer Ingelheim, Evotec, Biomerieux, antimicrobial resistance, antibiotic resistance, Aurobac Therapeutics
Biopharma Investment in China is Thriving Amid U.S. Downturn
BioSpace
Tue, 07/5/22 - 11:52 pm
Tags:
China, biotech, WuXi Biologics, Boehringer Ingelheim, Siemens Healthineers, AstraZeneca
Boehringer Ingelheim and BiomX Collaborate to Discover Inflammatory Bowel Disease Microbiome Biomarkers
BioSpace
Tue, 06/28/22 - 10:40 am
Tags:
Boehringer Ingelheim, BiomX, biomarkers, microbiome, IBD
Boehringer Ingelheim to incubate biotechs with Hong Kong R&D leader
Endpoints
Fri, 06/17/22 - 09:51 am
Tags:
Boehringer Ingelheim, R&D, Hong Kong, incubators
Boehringer Ingelheim Signs Option to Acquire Immunology Partner, Trutino Biosciences
BioSpace
Wed, 06/15/22 - 10:56 am
Tags:
Boehringer Ingelheim, Trutino Biosciences, M&A, cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.